ICAM1 and cystic fibrosis: By using flow cytometry, we showed that the treatment with conditioned medium from peripheral blood mononuclear cell-derived cMo-1s from CD patients (five males, one female) with CF hyperplasia led to a marked upregulation of ICAM1 expression and adipogenic specificity in MSC1 cells (Fig. 5l).